Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-08-28
1982-05-25
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3113
Patent
active
043316867
ABSTRACT:
Otitis Externa is treated in dogs by administering to the infected animal a dosage effective to alleviate the symptoms of the infection of a composition of beta-(1-adamantyl)-alpha,alpha-dimethylethylamine or its acid salt and at least one pharmaceutically acceptable carrier wherein the amine (or its salt) is from about 0.01 to about 95% by weight of the composition.
REFERENCES:
patent: 4100170 (1978-07-01), Shetty
Pennwalt Corporation
Rosen Sam
LandOfFree
Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2076878